FTC Tries Pulling Teva Into Cephalon Pay-For-Delay Suit

Law360, New York (December 10, 2013, 5:49 PM EST) -- The Federal Trade Commission asked a Pennsylvania federal judge Monday to add Teva Pharmaceutical Industries Ltd. as a defendant in its antitrust suit over payments Provigil maker Cephalon Inc. made to block generic versions of its drug, citing Teva's acquisition of the company. 

The FTC clarified that it was not trying to drag Teva — the world's largest generic pharmaceutical company — into the lawsuit over money it received from Cephalon to abstain from producing a generic form of the narcolepsy drug, but only because the...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

FEDERAL TRADE COMMISSION v. CEPHALON, INC.


Case Number

2:08-cv-02141

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Judge

MITCHELL S. GOLDBERG

Date Filed

May 8, 2008

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.